Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
1.150
-0.020 (-1.71%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Inovio Pharmaceuticals Employees
Inovio Pharmaceuticals had 112 employees as of December 31, 2025. The number of employees decreased by 22 or -16.42% compared to the previous year.
Employees
112
Change (1Y)
-22
Growth (1Y)
-16.42%
Revenue / Employee
$583
Profits / Employee
-$758,446
Market Cap
94.23M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Fractyl Health | 100 |
| PolyPid | 75 |
| Rani Therapeutics Holdings | 71 |
| eXoZymes | 32 |
| Oncolytics Biotech | 29 |
| NeurAxis | 24 |
| ProMIS Neurosciences | 11 |
| Aldeyra Therapeutics | 8 |
INO News
- 26 days ago - INOVIO Announces Pricing of $17.5 Million Public Offering - PRNewsWire
- 27 days ago - INOVIO Announces Proposed Public Offering - PRNewsWire
- 27 days ago - INOVIO to Participate in Upcoming Scientific Conference - PRNewsWire
- 6 weeks ago - Inovio Stock Up On Earnings, Pipeline Progress - Benzinga
- 6 weeks ago - Inovio Pharmaceuticals Earnings Call Transcript: Q4 2025 - Transcripts
- 6 weeks ago - INOVIO Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights - PRNewsWire
- 7 weeks ago - Inovio Pharmaceuticals Transcript: The Citizens Life Sciences Conference 2026 - Transcripts
- 7 weeks ago - INOVIO to Participate in Upcoming Scientific Conferences - PRNewsWire